Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended June 30, 2019

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/8/2026

1. HUVR:IN
2. ANET
3. NKE
4. PANW
5. CL
6. SNDK
7. TAP
8. DELL
9. ROIV
10. BAC

Go back to Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended June 30, 2019

Amphastar Pharma (AMPH) Tops Q2 EPS by 5c

August 7, 2019 5:02 PM EDT

Amphastar Pharma (NASDAQ: AMPH) reported Q2 EPS of $0.08, $0.05 better than the analyst estimate of $0.03. Revenue for the quarter came in at $79 million versus the consensus estimate of $77.61 million.

Dr. Jack Zhang, Amphastars Chief Executive Officer, commented: We are pleased that we have settled... More